Biologics Senior Regulatory Policy Analyst with 17 years of expertise in regulatory compliance and affairs. Focused on drug, biologic, and medical device policy, with a strong command of FDA and CMS regulations. Proven ability to lead cross-functional teams in developing regulatory strategies and ensuring adherence to federal, state, and international standards. Skilled in analytical, statistical, and problem-solving techniques within the biopharmaceutical sector.